TYLER PERKINS: Open Payments
NPI 1023887510 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,166 in 106 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $666 · 2025 $2,166
Food & beverage: $2,166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $529 |
| Janssen Pharmaceuticals, Inc | 7 | $308 |
| E.R. Squibb & Sons, L.L.C. | 15 | $269 |
| Vanda Pharmaceuticals Inc. | 9 | $229 |
| Neurocrine BioSciences, Inc. | 5 | $133 |
| Axsome Therapeutics, Inc. | 8 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| Alkermes, Inc. | 5 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Lundbeck LLC | 3 | $60 |
Products named: VRAYLAR, COBENFY, FANAPT, SPRAVATO, INGREZZA, INVEGA SUSTENNA, REXULTI, ARISTADA.
Industry payments across VA — which companies pay providers there.
